A randomized trial on effectiveness of artemether-lumefantrine versus artesunate plus amodiaquine for unsupervised treatment of uncomplicated Plasmodium falciparum malaria in Ghanaian children

Table 1 Baseline characteristics of randomized study participants

Characteristic	ASAQ	AL	p value^a
	n = 123	n = 123
Patients, n (percentage)
Agogo site	41 (33.3%)	39 (31.7%)	0.785
Agona site	82 (66.7%)	84 (68.3%)
Sex (male: female), n	68: 55	65: 58	0.701
Age, months (SD)	32.1 (± 16.1)	30.7 (± 13.7)	0.458
Weight-for-age^b, z-score (SD)	-0.93 (± 1.2)	-0.81 (± 1.1)	0.414
Axillary temperature,°C (SD)	38.1 (± 0.98)	38.0 (± 1.1)	0.891
Parasite density^c,/μl	38864	34255	0.572
Haemoglobin, g/dl (SD)	9.9 (± 1.9)	9.6 (± 1.7)	0.133

Please note:
Data are mean values (SD), unless otherwise indicated.
^a Determined using Wilcoxon test or χ² test. None of the parameters in both study arms was significantly different.
^b According to the WHO child growth standards. http://www.who.int/childgrowth/standards/weight_for_age/en/index.html
^c Geometric mean; parasite densities were determined from Giemsa-stained thick blood films.
ASAQ, artesunate plus amodiaquine; AL, artemether-lumefantrine
SD, standard deviation

ISSN: 1475-2875